NeoTX Scientific Publications

Selective T cell Redirection Proteins (STR) Enhance the Anti-Tumor Activity of Checkpoint Inhibitors (CPIs) and can Lead to Long-Lasting Immunity Against the Tumor.
Azulay M, Lifshits S, Shany E, Friedmann A, Hedlund G and Shahar M.
Poster presentation at SITC Annual Meeting 2019.
View the complete poster here.

Naptumomab Estafenatox induces T cell recognition, turning anti-PD-1 unresponsive “cold” tumors into “hot” responsive tumors.
Azulay M, Lifshits S, Friedmann A, Hedlund G, Törngren M, Shahar M.
Poster presentation at AACR Annual Meeting 2018.
View the complete poster here.